Clinical Trials Logo

Near Vision clinical trials

View clinical trials related to Near Vision.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05753189 Completed - Presbyopia Clinical Trials

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Start date: February 21, 2023
Phase: Phase 3
Study type: Interventional

Safety Study of the Long-Term Safety of LNZ101 in Presbyopic Subjects

NCT ID: NCT05728944 Completed - Presbyopia Clinical Trials

Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia

CLARITY
Start date: April 24, 2023
Phase: Phase 3
Study type: Interventional

Phase 3 Efficacy Study to evaluate the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

NCT ID: NCT05656027 Completed - Presbyopia Clinical Trials

Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia

CLARITY
Start date: December 19, 2022
Phase: Phase 3
Study type: Interventional

Phase 3 study to evaluate the safety and effectiveness of LNZ101 for the treatment of Presbyopia.

NCT ID: NCT05431543 Completed - Presbyopia Clinical Trials

Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

Start date: August 6, 2022
Phase: Phase 2
Study type: Interventional

To evaluate the safety and effectiveness of Aceclidine/Brimonidine (LNZ101) compared with Aceclidine (LNZ100) and vehicle in the treatment of Presbyopia.

NCT ID: NCT05359380 Completed - Cataract Clinical Trials

The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living

Start date: September 15, 2021
Phase:
Study type: Observational [Patient Registry]

Primary objective of this study is to identify the optimal task lighting conditions (in terms of light intensity and light temperature) for 10 activities of daily living (ADLs) that require near or intermediate vision acuity in a validated ADL simulation framework for a sample of patients who underwent presbyopic correction with bilateral multifocal intraocular lenses (IOLs) implantation, and to compare their capacity to perform ADLs (ADL scores) between three study groups (SG): SG1. patients implanted bilaterally with trifocal diffractive IOLs, SG2. patients implanted bilaterally with bifocal hybrid (diffractive-refractive) IOLs, SG3. patients implanted bilaterally with monofocal IOLs

NCT ID: NCT05005624 Completed - Presbyopia Clinical Trials

Validation of an Activities-of-daily-living Framework at Different Light Conditions

Start date: July 1, 2020
Phase:
Study type: Observational

Primary objective of this study is the construction and validation of an experimental environment for the simulation of a variety of near- and intermediate-vision activities of daily living (ADLs) in different combinations of light temperature and light intensity.

NCT ID: NCT04907955 Completed - Visual Impairment Clinical Trials

Visual Performance Following Implantation of Presbyopia Correcting IOLs

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of the current study was to compare the visual performance after bilateral implantation of the Panoptix IOL , or the AT LISA IOL or Tecnis Symfony IOL . The focus was on intermediate vision, defocus curves, and contrast sensitivity.

NCT ID: NCT04618224 Completed - Presbyopia Clinical Trials

Development and Validation of an Internet-based Near and Intermediate-vision Reading Test

wDDART
Start date: December 2, 2020
Phase:
Study type: Observational

Primary objective of our study is to develop and validate an internet-based digital near and intermediate-vision reading test in the greek language.

NCT ID: NCT04242836 Completed - Presbyopia Clinical Trials

Development and Validation of a Digital Optotype for Near Vision in Greek Language.

DeDART
Start date: March 28, 2019
Phase:
Study type: Observational [Patient Registry]

Primary objective of our study is to develop and validate a computer-based digital near-vision optotype based on the Greek version of the print MNREAD.

NCT ID: NCT04059289 Completed - Pseudophakia Clinical Trials

Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL

JJ-EYHANCE
Start date: January 7, 2020
Phase:
Study type: Observational

To compare (low contrast) visual acuity (VA) and contrast sensitivity (CS) - both at intermediate distances under nighttime driving conditions in a driving simulator between patients with bilateral EYHANCE IOLs OR bilateral conventional monofocal IOLs. Visual function testing in the driving simulator will be assessed without AND with (static) glare. Additionally: Assessment of individual response times, scanpath characteristics, evaluation of test retest reliability and self-evaluation of (intermediate) vision and visual impairment related to glare.